Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. DaVita Inc.
  6. Summary
    DVA   US23918K1088

DAVITA INC.

(DVA)
  Report
Delayed Nyse  -  04:00 2022-09-29 pm EDT
83.96 USD   -1.37%
09/13Davita Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
09/13DaVita Announces Adam H. Schechter to Join its Board of Directors
PR
09/13DaVita Inc. Appoints Adam H. Schechter to Board of Directors
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/23/2022 09/26/2022 09/27/2022 09/28/2022 09/29/2022 Date
86.31(c) 84.4(c) 82.78(c) 85.13(c) 83.96(c) Last
968 206 509 588 512 446 469 839 391 191 Volume
-1.35% -2.21% -1.92% +2.84% -1.37% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 11 750 M - -
Net income 2022 767 M - -
Net Debt 2022 10 228 M - -
P/E ratio 2022 10,9x
Yield 2022 -
Sales 2023 12 216 M - -
Net income 2023 901 M - -
Net Debt 2023 10 333 M - -
P/E ratio 2023 8,55x
Yield 2023 -
Capitalization 7 666 M 7 666 M -
EV / Sales 2022 1,52x
EV / Sales 2023 1,47x
Nbr of Employees 69 000
Free-Float 91,0%
More Financials
Company
DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows: - supply of dialysis services (96.5%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2021, services are insured through 2,815 dialysis centers serving nearly 203,100 patients in the United States, and through 339 dialysis centers serving nearly 39,900... 
More about the company
Ratings of DaVita Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about DAVITA INC.
09/13Davita Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
09/13DaVita Announces Adam H. Schechter to Join its Board of Directors
PR
09/13DaVita Inc. Appoints Adam H. Schechter to Board of Directors
CI
09/12Federman & Sherwood Investigates DaVita, Inc. for Data Breach
BU
08/23S&P Affirms DaVita 'BB' Issuer Credit Rating; Outlook Stable
MT
08/19US Stocks Close Lower on Friday as Aggressive Rate Hike Concerns Resurface
MT
08/19US Stocks End Friday Lower as Rate Hike Concerns Resurface Following St. Louis Fed Chie..
MT
08/19Sector Update: Health Care Stocks Cross Friday Finish Line Slightly Higher
MT
08/19Sector Update: Health Care Stocks a Rare Positive in Friday Trading
MT
08/19Midday Report: US Stocks Drop While Treasury Yields Rise; Bullard Reported..
MT
08/19UBS Upgrades DaVita to Buy From Neutral, Adjusts Price Target to $117 From $106
MT
08/03Barclays Adjusts DaVita Price Target to $103 From $128, Maintains Equal Weight Rating
MT
08/03A couple of hopes dashed
MS
08/03Analyst recommendations: Advanced Micro Devices, Uber, SBA Commu..
MS
08/02Deutsche Bank Adjusts DaVita's Price Target to $97 From $150, Maintains Buy Rating
MT
More news
News in other languages on DAVITA INC.
09/13DaVita Inc. nomme Adam H. Schechter au conseil d'administration
08/19Les actions américaines clôturent en baisse vendredi alors que les craintes d'une hauss..
08/19Les actions américaines terminent la journée de vendredi en baisse alors que les inquié..
08/19Mise à jour sectorielle : Les actions de soins de santé sont un ..
08/19Rapport de la mi-journée : Les actions américaines chutent tand..
More news
Analyst Recommendations on DAVITA INC.
More recommendations
ETFs positioned on DAVITA INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Vesper U.S. Large Cap Short-Term Reversal S...3.79%-1.77%United_States
Invesco S&P 500® Equal Weight Health Care E...1.32%-0.56%United_States
SPDR S&P Health Care Services ETF - USD1.25%-0.79%United_States
BMO Equal Weight US Health Care Index ETF - CAD1.11%-1.82%United_States
BMO Equal Weight U.S. Health Care Hedged to...1.07%-0.34%United_States
More ETFs positioned on DAVITA INC.
Chart DAVITA INC.
Duration : Period :
DaVita Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DAVITA INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 83,96 $
Average target price 101,14 $
Spread / Average Target 20,5%
EPS Revisions
Managers and Directors
Javier J. Rodriguez Chief Executive Officer & Director
Joel Ackerman Chief Financial Officer
Pamela M. Arway Chairman
Jeff Giullian Chief Medical Officer
James O. Hearty Chief Compliance Officer
Sector and Competitors